Miller PD - Search Results

1

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.

Bone HG, Cosman F, Miller PD, Williams GC, Hattersley G, Hu MY, Fitzpatrick LA, Mitlak B, Papapoulos S, Rizzoli R, Dore RK, Bilezikian JP, Saag KG. Bone HG, et al. Among authors: miller pd. J Clin Endocrinol Metab. 2018 Aug 1;103(8):2949-2957. doi: 10.1210/jc.2018-00163. J Clin Endocrinol Metab. 2018. PMID: 29800372 Free PMC article. Clinical Trial.

2

Bone histomorphometric changes after cyclic therapy with phosphate and etidronate disodium in women with postmenopausal osteoporosis.

Ott SM, Woodson GC, Huffer WE, Miller PD, Watts NB. Ott SM, et al. Among authors: miller pd. J Clin Endocrinol Metab. 1994 Apr;78(4):968-72. doi: 10.1210/jcem.78.4.8157728. J Clin Endocrinol Metab. 1994. PMID: 8157728 Clinical Trial.

3

Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis.

Miller PD. Miller PD. Br J Clin Pract. 1996 Jan-Feb;50(1):23-31. Br J Clin Pract. 1996. PMID: 8729598 Review.

4

Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.

Miller PD, Watts NB, Licata AA, Harris ST, Genant HK, Wasnich RD, Ross PD, Jackson RD, Hoseyni MS, Schoenfeld SL, Valent DJ, Chesnut CH 3rd. Miller PD, et al. Am J Med. 1997 Dec;103(6):468-76. doi: 10.1016/s0002-9343(97)00278-7. Am J Med. 1997. PMID: 9428829 Clinical Trial.

5

Bone densitometry: the best way to detect osteoporosis and to monitor therapy.

Miller PD, Zapalowski C, Kulak CA, Bilezikian JP. Miller PD, et al. J Clin Endocrinol Metab. 1999 Jun;84(6):1867-71. doi: 10.1210/jcem.84.6.5710. J Clin Endocrinol Metab. 1999. PMID: 10372677 Review.

6

Practical clinical application of biochemical markers of bone turnover: Consensus of an expert panel.

Miller PD, Baran DT, Bilezikian JP, Greenspan SL, Lindsay R, Riggs BL, Watts NB. Miller PD, et al. J Clin Densitom. 1999 Fall;2(3):323-42. doi: 10.1385/jcd:2:3:323. J Clin Densitom. 1999. PMID: 10548827 Review.

7

Bisphosphonates: safety and efficacy in the treatment and prevention of osteoporosis.

Greenspan SL, Harris ST, Bone H, Miller PD, Orwoll ES, Watts NB, Rosen CJ. Greenspan SL, et al. Among authors: miller pd. Am Fam Physician. 2000 May 1;61(9):2731-6. Am Fam Physician. 2000. PMID: 10821153 Free article.

8

The treatment of osteoporosis. Antiresorptive therapy.

Miller PD. Miller PD. Clin Lab Med. 2000 Sep;20(3):603-22, viii. Clin Lab Med. 2000. PMID: 10986624 Review.

9

Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms.

Miller PD, Woodson G, Licata AA, Ettinger MP, Mako B, Smith ME, Wang L, Yates SJ, Melton ME, Palmisano JJ. Miller PD, et al. Clin Ther. 2000 Dec;22(12):1433-42. doi: 10.1016/s0149-2918(00)83042-8. Clin Ther. 2000. PMID: 11192135 Clinical Trial.

10

New possibilities for diagnosis and treatment of osteoporosis.

Miller PD. Miller PD. Int J Fertil Womens Med. 2001 Jul-Aug;46(4):215-21. Int J Fertil Womens Med. 2001. PMID: 11563832 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

444 results

Search Page